{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:15:35Z","timestamp":1777529735527,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1171-2","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T10:23:52Z","timestamp":1543314232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Aleksandra","family":"Napieralska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"G\u0142owacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leszek","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"1171_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.critrevonc.2015.02.008","volume":"95","author":"J G\u00f3mez-Mill\u00e1n","year":"2015","unstructured":"G\u00f3mez-Mill\u00e1n J, Lara MF, Correa Generoso R, Perez-Rozos A, Lupi\u00e1\u00f1ez-P\u00e9rez Y, Medina Carmona JA. Advances in the treatment of prostate cancer with radiotherapy. Crit Rev Oncol Hematol. 2015;95:144\u201353. \n                    https:\/\/doi.org\/10.1016\/j.critrevonc.2015.02.008\n                    \n                  .","journal-title":"Crit Rev Oncol Hematol"},{"key":"1171_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/0360-3016(91)90244-X","volume":"20","author":"RK Ten Haken","year":"1991","unstructured":"Ten Haken RK, Forman JD, Heimburger DK, Gerhardsson A, McShan DL, Perez-Tamayo C, et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys. 1991;20:1317\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ijrobp.2015.09.035","volume":"94","author":"N Nabavizadeh","year":"2016","unstructured":"Nabavizadeh N, Elliott DA, Chen Y, Kusano AS, Mitin T, Thomas CR Jr, Holland JM. Image guided radiation therapy (IGRT) practice patterns and IGRT's impact on workflow and treatment planning: results from a National Survey of American Society for Radiation Oncology members. Int J Radiat Oncol Biol Phys. 2016;94:850\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2015.09.035\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijrobp.2013.02.021","volume":"87","author":"J De Los Santos","year":"2013","unstructured":"De Los Santos J, Popple R, Agazaryan N, Bayouth JE, Bissonnette JP, Bucci MK, et al. Image guided radiation therapy (IGRT) technologies for radiation therapy localization and delivery. Int J Radiat Oncol Biol Phys. 2013;87:33\u201345. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2013.02.021\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/COC.0b013e31827e4eb9","volume":"37","author":"S Das","year":"2014","unstructured":"Das S, Liu T, Jani AB, Rossi P, Shelton J, Shi Z, Khan MK. Comparison of image-guided radiotherapy technologies for prostate cancer. Am J Clin Oncol. 2014;37:616\u201323. \n                    https:\/\/doi.org\/10.1097\/COC.0b013e31827e4eb9\n                    \n                  .","journal-title":"Am J Clin Oncol"},{"key":"1171_CR6","unstructured":"Fraass BA, Jolly S, Eisbruch A. Conformal Therapy and Intensity- Modulated Radiation Therapy: Treatment planning, treatment delivery, and clinical results. In: clinical radiation oncology, 3rd ed. Gunderson LL, Tepper JE, Philadelphia 2012; 15: 287\u2013316."},{"key":"1171_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.ijrobp.2010.02.001","volume":"78","author":"JA Tanyi","year":"2010","unstructured":"Tanyi JA, He T, Summers PA, Mburu RG, Kato CM, Rhodes SM, et al. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys. 2010;78:1579\u201385. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2010.02.001\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijrobp.2008.03.015","volume":"73","author":"HT Chung","year":"2009","unstructured":"Chung HT, Xia P, Chan LW, Park-Somers E, Roach M 3rd. Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys. 2009;73:53\u201360. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2008.03.015\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00066-015-0919-y","volume":"192","author":"V Rudat","year":"2016","unstructured":"Rudat V, Nour A, Hammoud M, Alaradi A, Mohammed A. Image-guided intensity-modulated radiotherapy of prostate cancer: analysis of interfractional errors and acute toxicity. Strahlenther Onkol. 2016;192:109\u201317. \n                    https:\/\/doi.org\/10.1007\/s00066-015-0919-y\n                    \n                  .","journal-title":"Strahlenther Onkol"},{"key":"1171_CR10","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.hoc.2013.08.006","volume":"27","author":"R Khor","year":"2013","unstructured":"Khor R, Williams S. Contemporary issues in radiotherapy for clinically localized prostate cancer. Hematol Oncol Clin North Am. 2013;27:1137\u201362. \n                    https:\/\/doi.org\/10.1016\/j.hoc.2013.08.006\n                    \n                  .","journal-title":"Hematol Oncol Clin North Am"},{"key":"1171_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semradonc.2007.09.008","volume":"18","author":"PA Kupelian","year":"2008","unstructured":"Kupelian PA, Langen KM, Willoughby TR, Zeidan OA, Meeks SL. Image-guided radiotherapy for localized prostate cancer: treating a moving target. Semin Radiat Oncol. 2008;18:58\u201366.","journal-title":"Semin Radiat Oncol"},{"key":"1171_CR12","first-page":"7","volume":"65","author":"L Miszczyk","year":"2008","unstructured":"Miszczyk L, Leszczy\u0144ski W, Szczepanik K, Majewski W. Comparison of two image guided radiation therapy (IGRT) methods used for prostate cancer patients - CBCT and 2D-2D kV. Przeglad Lekarski. 2008;65:7\u20138.","journal-title":"Przeglad Lekarski"},{"key":"1171_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.11.054","volume":"71","author":"KM Langen","year":"2008","unstructured":"Langen KM, Willoughby TR, Meeks SL, Santhanam A, Cunningham A, Levine L, Kupelian PA. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys. 2008;71:1084\u201390. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2007.11.054\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/705604","volume":"2014","author":"S Goyal","year":"2014","unstructured":"Goyal S, Kataria T. Image guidance in radiation therapy: techniques and applications. Radiol Res Pract. 2014;2014:705604. \n                    https:\/\/doi.org\/10.1155\/2014\/705604\n                    \n                  .","journal-title":"Radiol Res Pract"},{"key":"1171_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.21037\/tau.2017.12.37","volume":"7","author":"A Dang","year":"2018","unstructured":"Dang A, Kupelian PA, Cao M, Agazaryan N, Kishan AU. Image-guided radiotherapy for prostate cancer. Transl Androl Urol. 2018;7:308\u201320. \n                    https:\/\/doi.org\/10.21037\/tau.2017.12.37\n                    \n                  .","journal-title":"Transl Androl Urol"},{"key":"1171_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijrobp.2011.11.047","volume":"84","author":"MJ Zelefsky","year":"2012","unstructured":"Zelefsky MJ, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X, et al. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;84:125\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2011.11.047\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1748-717X-8-137","volume":"8","author":"M Valeriani","year":"2013","unstructured":"Valeriani M, Bracci S, Osti MF, Falco T, Agolli L, De Sanctis V, Enrici RM. Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy. Radiat Oncol. 2013;8:137. \n                    https:\/\/doi.org\/10.1186\/1748-717X-8-137\n                    \n                  .","journal-title":"Radiat Oncol"},{"key":"1171_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1748-717X-9-44","volume":"9","author":"J Sveistrup","year":"2014","unstructured":"Sveistrup J, af Rosensch\u00f6ld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Radiat Oncol. 2014;9:44. \n                    https:\/\/doi.org\/10.1186\/1748-717X-9-44\n                    \n                  .","journal-title":"Radiat Oncol"},{"key":"1171_CR19","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ijrobp.2012.07.2376","volume":"85","author":"J Singh","year":"2013","unstructured":"Singh J, Greer PB, White MA, Parker J, Patterson J, Tang CI, et al. Treatment-related morbidity in prostate cancer: a comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markers. Int J Radiat Oncol Biol Phys. 2013;85:1018\u201323. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2012.07.2376\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1748-717X-6-145","volume":"6","author":"S Gill","year":"2011","unstructured":"Gill S, Thomas J, Fox C, Kron T, Rolfo A, Leahy M, et al. Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol. 2011;6:145. \n                    https:\/\/doi.org\/10.1186\/1748-717X-6-145\n                    \n                  .","journal-title":"Radiat Oncol"},{"key":"1171_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341\u20136. \n                    https:\/\/doi.org\/10.1016\/0360-3016(95)00060-C\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1171_CR22","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","volume":"44","author":"G van Andel","year":"2008","unstructured":"van Andel G, Bottomley A, Foss\u00e5 SD, Efficace F, Coens C, Guerif S, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44:2418\u201324. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2008.07.030\n                    \n                  .","journal-title":"Eur J Cancer"},{"key":"1171_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.radonc.2009.08.004","volume":"93","author":"C Fiorino","year":"2009","unstructured":"Fiorino C, Valdagni R, Rancati T, Sanguineti G. Dose-volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol. 2009;93:153\u201367. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2009.08.004\n                    \n                  .","journal-title":"Radiother Oncol"},{"key":"1171_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00066-016-0964-1","volume":"192","author":"C Cozzarini","year":"2016","unstructured":"Cozzarini C, Rancati T, Badenchini F, Palorini F, Avuzzi B, Degli Esposti C, et al. Baseline status and dose to the penile bulb predict impotence 1 year after radiotherapy for prostate cancer. Strahlenther Oncol. 2016;192:297\u2013304. \n                    https:\/\/doi.org\/10.1007\/s00066-016-0964-1\n                    \n                  .","journal-title":"Strahlenther Oncol"},{"key":"1171_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.radonc.2017.02.013","volume":"123","author":"DT Nguyen","year":"2017","unstructured":"Nguyen DT, O'Brien R, Kim JH, Huang CY, Wilton L, Greer P, et al. The first clinical implementation of a real-time six degree of freedom target tracking system during radiation therapy based on Kilovoltage Intrafraction monitoring (KIM). Radiother Oncol. 2017;123:37\u201342. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2017.02.013\n                    \n                  .","journal-title":"Radiother Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1171-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:14:47Z","timestamp":1574813687000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1171-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1171-2","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"4 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed according to the Helsinki Declaration and the Institutional Review Board Committee.No potential conflict of interest was reported by the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This retrospective study, based on standard treatment according to our institutional rules, does not need any specific consent. All patients submitted an informed, written consent to undergo treatment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"235"}}